Daito Pharmaceutical Co.,Ltd.

4577 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥1,253.00
-1.57%
Delayed · cached 15 min

Fair value analysis

4577
Daito Pharmaceutical Co.,Ltd.
Pharmaceuticals›Pharmaceutical
¥1,253.00
Close used for this calculation
¥2,397.14Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Profitability10/25
Returns15/25
Balance Sheet21/25
Efficiency25/25
Growth16/25
Strong
Quality radar
71Prof.10/25Ret.15/25Eff.25/25B.Sht21/25Growth16/25

Consensus fair value

¥2,397.14
Below FV
▲ +91.3% against the close used
Model range ¥509.63 – ¥3,542.98
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥509.63Fair value¥2,397.14Bull¥3,542.98
FairClose
52-week traded range
52W low ¥1,131.0052W high ¥1,500.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Daito Pharmaceutical Co.,Ltd. closed at ¥1,253.00, 47.7% below the consensus fair value of ¥2,397.14 drawn from 9 valuation models.

Financial DNA score 71/100 — Strong. P/E of 11.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥3,542.98
+182.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
¥2,111.04
+68.5%
√(22.5 × EPS × BVPS)
EPS=107.49, BVPS=1842.65
P/E Fair Value
¥2,149.80
+71.6%
EPS × 20x (sector P/E)
EPS=107.49, Sector P/E=20x
Peter Lynch (PEG)
¥615.92
-50.8%
EPS × Growth% (PEG = 1 is fair)
EPS=107.49, g=5.7%
EV/EBITDA
¥2,600.95
+107.6%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=8.02B
Dividend Discount (DDM)
¥509.63
-59.3%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=39.97, r=10%, g=2%
Book Value (P/B)
¥789.71
-37.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1842.65, ROE=6%, g=3%, r=10%
Reverse DCF
¥1,253.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -0.2% | Historical: -5.7%
Margin of Safety
¥1,950.96
+55.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2601.27, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.